ZOMIG |
311-C-90 |
ZOLMITRIPTAN |
311C90 |
ZOMIG-ZMT |
(S)-4-({3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL}METHYL)-1,3-OXAZOLIDIN-2-ONE |
4-[[3-(2-DIMETHYLAMINOETHYL)-1H-INDOL-5-YL]METHYL]OXAZOLIDIN-2-ONE |
ZOMIG® |
ZOLMITRIPTANUM |
chembl:CHEMBL1185 |
drugbank:00315 |
rxcui:135775 |
pubchem.compound:60857 |
chemidplus:139264-17-8 |
Drug Class | anti-migraine agents |
Year of Approval | 1997 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antimigraine agent |
Drug Categories | agents that produce hypertension |
Drug Categories | antidepressive agents |
Drug Categories | central nervous system depressants |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | monoamine oxidase a substrates |
Drug Categories | selective serotonin 5-ht1 receptor agonists |
Drug Categories | selective serotonin agonists |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 1b receptor agonists |
Drug Categories | serotonin 1d receptor agonists |
Drug Categories | serotonin-1b and serotonin-1d receptor agonist |
Drug Categories | triptans |
agonist (activating) |
Trial Name | zolmitriptan,Zomig |
Novel drug target | Established target |
Specific Action of the Ligand | Full agonist |
agonist (activating) |
Novel drug target | Established target |
Trial Name | zolmitriptan,Zomig |
Mechanism of Interaction | Serotonin 1d (5-HT1d) receptor agonist |
agonist (activating) |
Mechanism of Interaction | Serotonin 1b (5-HT1b) receptor agonist |
Direct Interaction | yes |
Trial Name | zolmitriptan,Zomig |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
agonist (activating) |
Trial Name | zolmitriptan,Zomig |
Novel drug target | Established target |
Specific Action of the Ligand | Full agonist |
ZOLMITRIPTAN | DrugBank Drug Name |
139264-17-8 | CAS Number |
Ag-zolmitriptan ODT | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
ZOLMITRIPTAN | Primary Drug Name |
Year of Approval | 1997 |
Drug Class | anti-migraine agents |
Drug Indications | antimigraine agent |
Drug Class | Small Molecule |
FDA Approval | approved |
ZOLMITRIPTAN | GuideToPharmacology Ligand Name |
D0NG7O | TTD Drug ID |